EXACT Operating Margin from 2010 to 2024
| EXAS Stock | USD 53.66 0.59 1.11% |
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.9 B or Research Development of 447.2 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
EXACT | Operating Margin |
Latest EXACT Sciences' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of EXACT Sciences over the last few years. It is EXACT Sciences' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.03) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
EXACT Operating Margin Regression Statistics
| Arithmetic Mean | (40.60) | |
| Coefficient Of Variation | (324.52) | |
| Mean Deviation | 65.17 | |
| Median | (0.47) | |
| Standard Deviation | 131.75 | |
| Sample Variance | 17,359 | |
| Range | 514 | |
| R-Value | 0.48 | |
| Mean Square Error | 14,473 | |
| R-Squared | 0.23 | |
| Significance | 0.07 | |
| Slope | 14.00 | |
| Total Sum of Squares | 243,021 |
EXACT Operating Margin History
About EXACT Sciences Financial Statements
EXACT Sciences shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.